Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Upbound (UPBD) Asset Writedowns and Impairment (2016 - 2025)

Upbound (UPBD) has disclosed Asset Writedowns and Impairment for 17 consecutive years, with $74.2 million as the latest value for Q4 2025.

  • Quarterly Asset Writedowns and Impairment rose 1593.18% to $74.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $75.1 million through Dec 2025, up 288.3% year-over-year, with the annual reading at $75.1 million for FY2025, 288.3% up from the prior year.
  • Asset Writedowns and Impairment for Q4 2025 was $74.2 million at Upbound, up from $958000.0 in the prior quarter.
  • The five-year high for Asset Writedowns and Impairment was $74.2 million in Q4 2025, with the low at -$14.8 million in Q2 2025.
  • Average Asset Writedowns and Impairment over 5 years is $8.4 million, with a median of $4.6 million recorded in 2021.
  • Peak annual rise in Asset Writedowns and Impairment hit 1593.18% in 2025, while the deepest fall reached 477.92% in 2025.
  • Over 5 years, Asset Writedowns and Impairment stood at $4.6 million in 2021, then skyrocketed by 43.44% to $6.6 million in 2022, then soared by 294.46% to $25.9 million in 2023, then plummeted by 83.06% to $4.4 million in 2024, then surged by 1593.18% to $74.2 million in 2025.
  • According to Business Quant data, Asset Writedowns and Impairment over the past three periods came in at $74.2 million, $958000.0, and -$14.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.